Pharmaceuticals(50)

  • Treating Drug-Resistant Lung Cancer Using a Combination of Antibodies (No. T4-1774)

    A novel method to treat tyrosine kinase inhibitor (TKI) resistant cancer by using a combination of three antibodies that target EGFR (ERBB1), HER2 (ERBB2), and HER3 (ERBB3) receptors. ... Read more
    Extension Service Yosef Yarden

    Yosef Yarden

    Faculty of Biology

    5635
  • Treatment of Heart Failure by Inducing Cardiomyocyte Proliferation (No. T4-1752)

    Regulating ErbB2 signaling in cardiomyocytes (CM) as novel treatment for heart diseases by inducing regeneration of cardiac tissue. ... Read more
    Full Professor Eldad Tzahor

    Eldad Tzahor

    Faculty of Biology

    5623
  • Treating Cancer and Collagen-Associated Diseases by Using Anti-LOXL-2 Antibody (No. T4-1743)

    An innovative method for treating diseases associated with dysregulation of collagen fibers in the extracellular matrix (ECM), such as cancer and fibrosis, by targeting LOXL-2. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    5611
  • Treatment for Inflammatory Diseases and Cancer (No. T4-1733)

    The development of kinase inhibitors to treat inflammatory diseases was proved beneficial, however, designing specific inhibitors with minimal side effects and prolonged efficacy is challenging as drug resistance often develops. ... Read more
    Full Professor Rony Seger

    Rony Seger

    Faculty of Biology

    5605
  • Preventing Infections Using Lipid Based Molecules (No. T4-1673)

    Sphingosine (SPH), a natural bactericidal agent which acts as a part of the human innate immune system in the skin, was found to be an effective treatment and prophylaxis for bacterial lung infections in cystic fibrosis (CF) mice. ... Read more
    Full Professor Anthony H. Futerman

    Anthony H. Futerman

    Faculty of Biochemistry

    5584
  • Magnetic resonance imaging (MRI) Of Tissue Fibrosis Without Contrast Agent (No. T4-1665)

    Cardiac fibrosis is a scarring event in the cardiac muscle that causes abnormalities in cardiac function and significantly increases the risk of sudden cardiac death. ... Read more
    Full Professor Michal Neeman

    Michal Neeman

    Faculty of Biology

    5575
  • Optimizing T Cell Receptor Avidity for Adoptive T Cell Therapies (No. T4-1662)

    Using affinity maturated TCRs to generate reactive T cells ... Read more
    Emeritus Rachel Lea Eisenbach

    Rachel Lea Eisenbach

    Faculty of Biology

    5572
  • Anti-QSOX1 Antibody for Treating Cancer and Metastasis (No. T4-1642)

    Cancer, and especially cancer metastasis, is a leading cause of death worldwide. Research in recent years highlighted the importance of the extracellular matrix (ECM) surrounding the tumor in cancer progression metastasis formation. ... Read more
    Full Professor Deborah Fass

    Deborah Fass

    Faculty of Chemistry

    5560
  • Antibody Based Therapy to Treat Cancer and GI Related Diseases (No. T4-1640)

    A novel therapeutic antibody against MMP-7, with exceptional specificity, for the treatment of aggressive cancers. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    5557
  • Treating Cancer by Inhibiting Nuclear Entry of MAPK Cascade Proteins (No. T4-1446)

    Inhibition of Nuclear Entry of MAPK Cascade Proteins as a Novel Mechanism for Treating Cancer ... Read more
    Full Professor Rony Seger

    Rony Seger

    Faculty of Biology

    5473

Pages

Subscribe to Pharmaceuticals